Nothing Special   »   [go: up one dir, main page]

Giraldi et al., 1977 - Google Patents

Lysosomal enzyme inhibitors and antimetastatic activity in the mouse

Giraldi et al., 1977

View PDF
Document ID
17955080733035703456
Author
Giraldi T
Nisi C
Sava G
Publication year
Publication venue
European Journal of Cancer (1965)

External Links

Snippet

Abstract Saccharo-1, 4-lactone, a β-glucuronidase inhibitor, and three protease inhibitors did not affect primary tumour growth when tested against Lewis lung carcinoma in mice. The number of lung metastases was significantly reduced by aprotinin only. The inactivity of …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

Similar Documents

Publication Publication Date Title
Giraldi et al. Lysosomal enzyme inhibitors and antimetastatic activity in the mouse
Fishman et al. L-phenylalanine: an organ specific, stereo-specific inhibitor of human intestinal alkaline phosphatase
Alonso et al. Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis
Neuzil et al. α-Tocopheryl succinate, an agent with in vivo anti-tumour activity, induces apoptosis by causing lysosomal instability
Hikino et al. Antihepatotoxic actions of flavonolignans from Silybum marianum fruits
Novogrodsky et al. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors
Lam et al. Effects of citrus limonoids on glutathione S-transferase activity in mice
Pradeep et al. Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice
Wigler et al. Induction of plasminogen activator in cultured cells by macrocyclic plant diterpene esters and other agents related to tumor promotion
Sawaya et al. Plasminogen activator activity and molecular weight patterns in human brain tumors
Koketsu et al. Inhibitory effects of 1, 3-selenazol-4-one derivatives on mushroom tyrosinase
Bogenmann et al. Role of plasminogen in matrix breakdown by neoplastic cells
Okada et al. The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells
KR20010033150A (en) Multicatalytic Protease Inhibitors for Use as Anti-Tumor Agents
Sawaya et al. Alpha-1-antitrypsin in human brain tumors
Issandou et al. Diacylglycerols, unlike phorbol esters, do not induce homologous desensitization or down-regulation of protein kinase C in Swiss 3T3 cells
Giraldi et al. Neutral proteinase inhibitors and antimetastatic effects in mice
Keren et al. Identification of cell surface cathepsin B-like activity on murine melanomas and fibrosarcomas: modulation by butanol extraction
CZ283972B6 (en) Pharmaceutical preparation exhibiting modulation effect on malignant tumors and the use thereof
Drew et al. Inhibition of the protein kinase C pathway promotes anti-CD95-induced apoptosis in Jurkat T cells.
Krivoy et al. The preservation of bradykinin by phenothiazines in vitro
Ferretti et al. Effects of Agelas oroides and Petrosia ficiformis crude extracts on human neuroblastoma cell survival
Spath et al. Diethyldithiocarbamate inhibits scheduled and unscheduled DNA synthesis of rat thymocytes in vitro and in vivo—dose-effect relationships and mechanisms of action
JPH07196490A (en) Tumor metastasis inhibitor
Giraldi et al. Mechanism of the antimetastatic action of N-diazoacetylglycinamide in mice bearing Lewis lung carcinoma